A decade ago Mark Pruzanski was running Intercept Pharmaceuticals Inc alone out of his West Village apartment and was  in debt At one point the company had  in its checking account  By last Friday the person firm was the hottest company in the biotechnology sector its market capitalization having soared more than sixfold over the course of one week to  billion from  billion after its liverdisease drug performed surprisingly well in a clinical trial funded by the National Institutes of Health
  